Abe S, Golomb H M, Rowley J D, Mitelman F, Sandberg A A
Cancer. 1980 Jan 1;45(1):84-90. doi: 10.1002/1097-0142(19800101)45:1<84::aid-cncr2820450115>3.0.co;2-v.
The bone marrow chromosomes in six ANLL patients with a missing Y were examined. In all of six cases, the missing Y was the only chromosomal abnormality at diagnosis, and it persisted through their clinical courses. One patient had a shift from the 45,X to a 47,XX, +5, 13q + karyotype in the terminal phase of the disease. The findings indicate that the 45,X cells were not involved in further karyotypic progression, and that the leukemic process usually seemed to involve the 46,XY cell rather than the 45,X cells. Based on the data of the current study and that in the literature, it appears that the presence of missing Y in ANLL may afford a rather benign clinical course to such patients when compared to that of the ANLL patients with a missing Y. It is suggested that the age of the patients, karyotypic differences and degree of a missing Y in the marrow cells may affect the clinical course of ANLL.
对6例Y染色体缺失的急性非淋巴细胞白血病(ANLL)患者的骨髓染色体进行了检查。在所有6例病例中,Y染色体缺失是诊断时唯一的染色体异常,并且在整个临床病程中持续存在。1例患者在疾病终末期从45,X核型转变为47,XX,+5,13q+核型。这些发现表明,45,X细胞未参与进一步的核型演变,并且白血病过程似乎通常涉及46,XY细胞而非45,X细胞。根据本研究及文献中的数据,与无Y染色体缺失的ANLL患者相比,ANLL中Y染色体缺失的存在似乎可能为这类患者提供一个相对良性的临床病程。提示患者年龄、核型差异以及骨髓细胞中Y染色体缺失程度可能影响ANLL的临床病程。